Agios Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT LLC | 11/14/2025 | 5.78 M | $232.05 M | 0.24% | 9.98% |
| VANGUARD GROUP INC | 11/07/2025 | 5.60 M | $224.98 M | -1.36% | 9.67% |
| BLACKROCK, INC. | 11/12/2025 | 4.55 M | $182.47 M | -5.96% | 7.85% |
| BELLEVUE GROUP AG | 11/14/2025 | 3.71 M | $149.11 M | 3.47% | 6.41% |
| ERSTE ASSET MANAGEMENT GMBH | 11/12/2025 | 2.76 M | $108.58 M | 18.84% | 4.77% |
| PARADIGM BIOCAPITAL ADVISORS LP | 11/14/2025 | 2.67 M | $107.32 M | 134.01% | 4.61% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 2.47 M | $99.20 M | 485.46% | 4.27% |
| COMMODORE CAPITAL LP | 11/14/2025 | 2.34 M | $93.86 M | 0.57% | 4.04% |
| STATE STREET CORP | 11/14/2025 | 2.26 M | $90.83 M | 15.97% | 3.91% |
| MACQUARIE GROUP LTD | 11/13/2025 | 1.96 M | $78.60 M | 3.03% | 3.38% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2025 | 1.66 M | $66.51 M | -27.14% | 2.86% |
| TCG CROSSOVER MANAGEMENT, LLC | 11/17/2025 | 1.43 M | $57.40 M | 105.17% | 2.47% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 1.42 M | $56.86 M | 0.75% | 2.44% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 11/14/2025 | 1.28 M | $51.37 M | 0.00% | 2.21% |
| CALIGAN PARTNERS LP | 11/14/2025 | 1.13 M | $45.41 M | 5.60% | 1.95% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 1.13 M | $45.36 M | 0.87% | 1.95% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 1.02 M | $40.99 M | -7.67% | 1.76% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 11/07/2025 | 987.34 K | $39.63 M | -2.91% | 1.70% |
| CALIGAN PARTNERS LP | 11/14/2025 | 975.00 K | $39.14 M | 100.00% | 1.68% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2025 | 958.54 K | $38.48 M | -3.15% | 1.65% |
| DEUTSCHE BANK AG\ | 11/13/2025 | 926.73 K | $37.20 M | 0.56% | 1.60% |
| ARMISTICE CAPITAL, LLC | 11/17/2025 | 900.00 K | $36.13 M | 100.00% | 1.55% |
| FISHER ASSET MANAGEMENT, LLC | 11/12/2025 | 870.15 K | $34.93 M | -0.84% | 1.50% |
| GW&K INVESTMENT MANAGEMENT, LLC | 11/12/2025 | 852.94 K | $34.24 M | -1.80% | 1.47% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 804.77 K | $32.30 M | 24.18% | 1.39% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2025 | 800.00 K | $32.11 M | 1.14% | 1.38% |
| ARMISTICE CAPITAL, LLC | 11/17/2025 | 764.00 K | $30.67 M | -34.59% | 1.32% |
| ARROWMARK COLORADO HOLDINGS LLC | 11/14/2025 | 679.92 K | $27.29 M | 3.22% | 1.17% |
| SCS CAPITAL MANAGEMENT LLC | 11/13/2025 | 598.77 K | $24.03 M | -0.88% | 1.03% |
| NORTHERN TRUST CORP | 11/14/2025 | 555.41 K | $22.29 M | -0.25% | 0.96% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 11/13/2025 | 530.10 K | $21.28 M | 4.92% | 0.92% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2025 | 495.49 K | $19.89 M | 100.00% | 0.86% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2025 | 495.34 K | $19.88 M | 10.81% | 0.86% |
| CITADEL ADVISORS LLC | 11/14/2025 | 491.98 K | $19.75 M | -54.51% | 0.85% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 482.19 K | $19.35 M | 1.29% | 0.83% |
| MORGAN STANLEY | 11/14/2025 | 417.00 K | $16.74 M | 42.82% | 0.72% |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 11/12/2025 | 402.94 K | $16.17 M | 3.32% | 0.70% |
| JANE STREET GROUP, LLC | 11/14/2025 | 395.12 K | $15.86 M | 1,079.85% | 0.68% |
| CAPTION MANAGEMENT, LLC | 11/14/2025 | 386.60 K | $15.52 M | 138.05% | 0.67% |
| D. E. SHAW & CO., INC. | 11/14/2025 | 367.75 K | $14.76 M | -38.32% | 0.63% |
| LEGAL & GENERAL GROUP PLC | 11/13/2025 | 322.93 K | $12.96 M | 402.19% | 0.56% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2025 | 290.90 K | $11.68 M | 100.00% | 0.50% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/18/2025 | 272.16 K | $10.69 M | -7.66% | 0.47% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 270.10 K | $10.84 M | 1.29% | 0.47% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 267.30 K | $10.73 M | 345.50% | 0.46% |
| PALO ALTO INVESTORS LP | 11/14/2025 | 265.50 K | $10.66 M | -1.22% | 0.46% |
| SUMMITTX CAPITAL, L.P. | 11/14/2025 | 262.98 K | $10.56 M | 100.00% | 0.45% |
| EAGLE HEALTH INVESTMENTS LP | 11/07/2025 | 246.23 K | $9.88 M | -25.57% | 0.43% |
| UBS GROUP AG | 11/13/2025 | 242.81 K | $9.75 M | 104.33% | 0.42% |
| MARSHALL WACE, LLP | 11/13/2025 | 226.82 K | $9.10 M | -66.87% | 0.39% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Agios Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 332 institutional investors and hedge funds held shares of Agios Pharmaceuticals, Inc.. The most heavily invested institutionals were:
FARALLON CAPITAL MANAGEMENT LLC: 5.78 M
VANGUARD GROUP INC: 5.6 M
BlackRock, Inc.: 4.55 M
Bellevue Group AG: 3.71 M
Erste Asset Management GmbH: 2.76 M
Paradigm Biocapital Advisors LP: 2.67 M
109.60% of Agios Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 82.26 M shares in the last 24 months. This purchase volume represents approximately $2.26 B in transactions.